Description:
PURPOSE OF THIS RFA
Ischemic stroke is the third leading cause of death in the United States. With the
aging of the population, the number of stroke patients in the US is likely to grow.
There is a critical need to develop safe and effective therapies to improve the
clinical management of stroke patients. Thus, the NHLBI and the NINDS invite
research applications that will improve the understanding of brain hemostasis,
identify new molecular targets, explore promising agents, and develop novel
therapeutics for cerebral ischemia. This program intends to support basic,
translational, and early clinical studies.
Who can apply:
Anyone/General Public
City Or Township Governments
County Governments
Federally Recognized Indian Tribal Governments
Independent School Districts
Individual/Family
Minority Group
Native American Organization
Non-Government - General
Nonprofits Having A 501(C)(3) Status With The IRS, Other Than Institutions Of Higher Education
Nonprofits That Do Not Have A 501(C)(3) Status With The IRS, Other Than Institutions Of Higher Education
Other Private Institution/Organization
Private Institutions Of Higher Education
Private Nonprofit Institution/Organization (Includes Institutions Of Higher Education, Hospitals)
Profit Organization
Public And State Controlled Institutions Of Higher Education
Public Housing Authorities/Indian Housing Authorities
Quasi-Public Nonprofit Institution/Organization
Small Business (Less Than 500 Employees
Special District Governments
State (Includes District Of Columbia; Includes Institutions Of Higher Education And Hospitals)
U.S. Territories And Possessions (Includes Institutions Of Higher Education, Hospitals)
Eligible functional categories:
Funding Sources:
Blood Diseases and Resources Research
Extramural Research Programs in the Neurosciences and Neurological Disorders
More Information:
http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-05-004.html
If you have problems accessing the full announcement, please contact:
NIH OER Webmaster
Address Info: